MedTrace Logo

Arthritis Research UK Gout Treatment Trial - Phase 2

NCT01477346 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 517

Last updated 2017-01-05

No results posted yet for this study

Summary

The purpose of this study is to determine in community-derived patients with gout the effectiveness, and cost effectiveness, of a nurse-led complex intervention that reflects recommended best practice (including patient information concerning gout, its prognosis and its non-pharmacological and drug options).

Conditions

Interventions

OTHER

Nurse intervention

Complex package of care involving patient information and advice concerning lifestyle modification and recommended drug therapy.

OTHER

Standard care

Continuing standard General Practitioner led care.

Sponsors & Collaborators

  • Arthritis Research UK

    collaborator OTHER

  • University of Nottingham

    lead OTHER

Principal Investigators

  • Michael Doherty, MA MD FRCP · University of Nottingham

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01477346 on ClinicalTrials.gov